Trial Profile

Phase I trial of EP 217609 in volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 07 Jun 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs EP 217609 (Primary)
Indications Thrombosis
Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
Sponsors Endotis Pharma

Most Recent Events

03 Jun 2016 Results published in the European Journal of Clinical Pharmacology
07 Mar 2011 New trial record
08 Jul 2010 Results presented at the 21st International Congress on Thrombosis, according to a Endotis media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com